| LC control no. | sh 92003700 |
|---|---|
| LC classification | RC271.P27 Cancer chemotherapy |
| Topical heading | Paclitaxel |
| Variant(s) | Taxol Taxol (Trademark) |
| See also | Alkaloids Antineoplastic agents |
| Found in | Work cat.: 95-2352: Paclitaxel in cancer treatment, c1995. 92-170036: U.S. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy. Exclusive agreements between Federal agencies and Bristol-Myers Squibb Co. for drug development, 1992. MESH (Paclitaxel x Taxol; was Taxol 1993-94) Dict. of drugs: [33069-62-4] (NSC 125973) Am. drug index, 1990 (Taxol (bile salts, laxative)) Chem. abst. (Taxol A; Taxol B) |
| Not found in | Merck |
 |  |  |